114 related articles for article (PubMed ID: 3766908)
1. Clinical and in vitro antiproliferative properties of recombinant DNA-derived human interferon-alpha 2.
Freedman MH; Estrov Z; Williams BR; Gelfand EW
Am J Pediatr Hematol Oncol; 1986; 8(3):178-82. PubMed ID: 3766908
[TBL] [Abstract][Full Text] [Related]
2. Growth inhibitory effect of gene-cloned interferons on human myeloblast colonies.
Freedman MH; Fish E; Estrov Z; Grunberger T; Williams BR
Exp Hematol; 1985 Oct; 13(9):932-6. PubMed ID: 3862600
[TBL] [Abstract][Full Text] [Related]
3. Effect of alpha interferon on growth of leukemic and normal hematopoietic progenitors. Synergism with H2 histamine receptor antagonists.
Douer D; Kneller A; Ben-Bassat I; Chitayat SD; Shaked N; Salzberg S; Ramot B
Exp Hematol; 1989 Jun; 17(5):443-8. PubMed ID: 2714424
[TBL] [Abstract][Full Text] [Related]
4. In vivo sensitivity and resistance of chronic myelogenous leukemia cells to alpha-interferon: correlation with receptor binding and induction of 2',5'-oligoadenylate synthetase.
Rosenblum MG; Maxwell BL; Talpaz M; Kelleher PJ; McCredie KB; Gutterman JU
Cancer Res; 1986 Sep; 46(9):4848-52. PubMed ID: 2942242
[TBL] [Abstract][Full Text] [Related]
5. Phase I-II study of continuous-infusion high-dose human lymphoblastoid interferon and the in vitro sensitivity of leukemic progenitors in nonlymphocytic leukemia.
Mirro J; Dow LW; Kalwinsky DK; Dahl GV; Weck P; Whisnant J; Murphy SB
Cancer Treat Rep; 1986 Mar; 70(3):363-7. PubMed ID: 3456833
[TBL] [Abstract][Full Text] [Related]
6. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the antiproliferative properties of recombinant human IFN-alpha 2 and IFN-omega in human bone marrow culture.
Tiefenthaler M; Geisen F; Schirmer M; Konwalinka G
J Interferon Cytokine Res; 1997 Jun; 17(6):327-9. PubMed ID: 9197999
[TBL] [Abstract][Full Text] [Related]
8. Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: correlation of receptor binding, 2',5'-oligoadenylate synthetase and protein kinase activity.
Rosenblum MG; Yung WK; Kelleher PJ; Ruzicka F; Steck PA; Borden EC
J Interferon Res; 1990 Apr; 10(2):141-51. PubMed ID: 2140395
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
Broxmeyer HE; Lu L; Platzer E; Feit C; Juliano L; Rubin BY
J Immunol; 1983 Sep; 131(3):1300-5. PubMed ID: 6193183
[TBL] [Abstract][Full Text] [Related]
10. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
[TBL] [Abstract][Full Text] [Related]
11. The interaction of recombinant HuIFN-gamma 1 and recombinant HuIFN-alpha 2 on the 2-5A system in two distinct cell types.
Fish EN; Banerjee K
Prog Clin Biol Res; 1985; 202():385-90. PubMed ID: 3008171
[No Abstract] [Full Text] [Related]
12. Synergistic effects of HuIFN-gamma on 2',5'-oligoadenylate synthetase induction by HuIFN-alpha.
Justesen J; Berg K
J Interferon Res; 1986 Aug; 6(4):445-54. PubMed ID: 3095443
[TBL] [Abstract][Full Text] [Related]
13. The suppressive effects of recombinant human tumor necrosis factor-alpha on normal and malignant myelopoiesis: synergism with interferon-gamma.
Herrmann F; Bambach T; Bonifer R; Lindemann A; Riedel D; Oster W; Mertelsmann R
Int J Cell Cloning; 1988 Jul; 6(4):241-61. PubMed ID: 3138311
[TBL] [Abstract][Full Text] [Related]
14. Effects of interferon and retinoic acid on the growth and differentiation of clonogenic leukemic cells from acute myelogenous leukemia patients treated with recombinant leukocyte-alpha A interferon.
Gallagher RE; Lurie KJ; Leavitt RD; Wiernik PH
Leuk Res; 1987; 11(7):609-19. PubMed ID: 3475513
[TBL] [Abstract][Full Text] [Related]
15. Phase I/II trial of interferon-beta-serine in patients with renal cell carcinoma: immunological and biological effects.
Rinehart JJ; Young D; Laforge J; Colborn D; Neidhart JA
Cancer Res; 1987 May; 47(9):2481-5. PubMed ID: 3567933
[TBL] [Abstract][Full Text] [Related]
16. Combined effect of interferon-gamma and tumor necrosis factor-alpha causing suppression of leukemic blast progenitors in acute myeloblastic leukemia.
Nara N
Leuk Lymphoma; 1993 Jun; 10(3):201-7. PubMed ID: 7693101
[TBL] [Abstract][Full Text] [Related]
17. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia.
Bardawil RG; Ratain MJ; Golomb HM; Bitter MA; Groves C; Vardiman JW
Leukemia; 1987 Apr; 1(4):340-3. PubMed ID: 3669760
[TBL] [Abstract][Full Text] [Related]
18. Eosinophils activation in post-autologous bone marrow transplanted patients treated with subcutaneous interleukin-2 and interferon-alpha 2A immunotherapy.
Fabian I; Kravtsov V; Elis A; Gurevitch O; Ackerstein A; Slavin S; Nagler A
Leukemia; 1994 Aug; 8(8):1379-84. PubMed ID: 8057677
[TBL] [Abstract][Full Text] [Related]
19. Interferon-beta induced remission in a hairy cell leukemia patient resistant to interferon-alpha.
Michalevicz R; Aderka D; Frisch B; Revel M
Leuk Res; 1988; 12(10):845-51. PubMed ID: 3199843
[TBL] [Abstract][Full Text] [Related]
20. Growth requirements for human acute lymphoblastic leukemia cells: refinement of a clonogenic assay.
Estrov Z; Freedman MH
Cancer Res; 1988 Oct; 48(20):5901-7. PubMed ID: 3048651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
